JUL 27, 2020 8:37 AM PDT

Identifying Tumor Cells in the Blood with Artificial Intelligence

WRITTEN BY: Jasper Cantrell

Cancer diagnostics is an area of keen interest in the fight against cancer. Cancer often slips by routine checkups and veils itself until it’s in later stages. At this point, patients have limited options, and the prognosis tends to be grim.

Diagnostic research has become a key focus to catch cancer at early stages and give patients a significantly better chance. Biomarkers are the current go-to method for this, and circulating tumor cells are an example of a cellular biomarker. These cancer cells escape the confines of a tumor and enter the bloodstream. There they can be found by blood tests and diagnose cancer before it can become a genuine problem.

However, circulating tumor cells suffer from a fatal flaw. They are present in the bloodstream at such minuscule levels that it requires a rather large amount of blood to enrich them in tests. Even worse, some cancers do not present critical targets that many tests use to identify them. A team from Lehigh University in Pennsylvania hope to develop a new way to identify these tumor cells, with the help of artificial intelligence.

Machine learning is a method of developing modern artificial intelligence programs. These computer programs can learn how to identify unique characteristics in large datasets. This study utilized one of these programs specialized in identifying unique characteristics in images. The program would “train” itself on a set of images taken from cultured cells and then validate itself for accuracy. If functional, it could be used on patient blood samples to identify circulating tumor cells.

As a control, the team used cultured circulating tumor cells to obtain images to train the program. The resulting program could identify the tumor cells in samples with an accuracy of 97%. The team moved on to testing patient blood cells.

Unfortunately, the team could only get thirty-one images from two patients. As datasets for machine learning programs need to be large, the had to conduct a type of data augmentation to expand thirty-one images to one thousand. The resulting dataset had one thousand samples, which was enough to train the program, which achieved an accuracy of just under 90%.

The team visualized the data output from the program and found it reliably separated circulating tumor cells from similar cells in a sample. They noted that any issues the program might have been due to image quality. They state that the higher accuracy of the control indicates that the programs would benefit from a larger dataset to improve upon its reliability.

All in all, this study shows the promise of deep learning and other artificial intelligence methods in diagnostic research. The study concludes, “As we mentioned, CTCs from RCC patient cannot be correctly isolated by CellSearch. If combined with molecular characterization, this label-free method of statistical analysis for CTCs would provide useful information to help choose the optimal therapy for mRCC patients.”

Sources: Nature Scientific Reports, ecancer

About the Author
  • Hey everyone! My name is Jasper and, considering I am pretty new here to Labroots, I figured I would introduce myself. I received my bachelor’s from the University of California at Riverside back in 2016. I started off my career a few years ago with a job at a University over in New York, before moving over into the industry. I'm happy to be writing content for Labroots, and I hope you enjoy it!
You May Also Like
NOV 26, 2020
Clinical & Molecular DX
Routine Diagnostic Tests Linked to a 59 Percent Increase in Testicular Cancer Risk
NOV 26, 2020
Routine Diagnostic Tests Linked to a 59 Percent Increase in Testicular Cancer Risk
New research has revealed that exposure to radiation from diagnostic procedures such as X-rays could contribute to an el ...
DEC 01, 2020
Cancer
The price tag of prostate cancer treatment
DEC 01, 2020
The price tag of prostate cancer treatment
New research published in The Journal of Urology from the Official Journal of the American Urological Association&n ...
DEC 24, 2020
Cancer
Seven DNA fingerprints determine genetic predisposition for cancer
DEC 24, 2020
Seven DNA fingerprints determine genetic predisposition for cancer
New research published in Science Advances is attempting to change the way that we think about cancer. The research ...
DEC 28, 2020
Cell & Molecular Biology
How an Herbal Compound May Fight Pancreatic Cancer
DEC 28, 2020
How an Herbal Compound May Fight Pancreatic Cancer
For centuries, Chinese practitioners have used herbs to treat all kinds of ailments. New research has shown that one of ...
DEC 28, 2020
Drug Discovery & Development
Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells
DEC 28, 2020
Anti-Diarrhea Drug Kills Aggressive Brain Cancer Cells
Glioblastoma is a very aggressive and lethal form of brain cancer that responds poorly to chemotherapy in children and a ...
JAN 19, 2021
Cancer
Report on alcohol-related cancer incidence and mortality by state
JAN 19, 2021
Report on alcohol-related cancer incidence and mortality by state
New research published in Cancer Epidemiology suggests that alcohol consumption is associated with cancer incidence and ...
Loading Comments...